Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00668083

Acronym

Sorse

Enrollment

214

Registered

2008-04-28

Start date

2007-09-30

Completion date

2008-07-31

Last updated

2010-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

second line, Prostate Cancer, bicalutamide, biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg

Brief summary

Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Healthy volunteers

Inclusion criteria

* non metastatic Prostate Cancer * previous treatment with bicalutamide 150mg * biochemical relapse/progression

Exclusion criteria

* use of other treatments for Prostate Cancer

Design outcomes

Primary

Measure	Time frame
Hormonal sensitivity to second line treatment for CaP after Bicalutamide	six months

Secondary

Measure	Time frame
median duration of second and third line treatments;	six months

Countries

Italy

Outcome results